Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CoreWeave, Inc. filings document the regulatory record for an AI cloud infrastructure company listed on Nasdaq with Class A common stock. The company’s 8-K reports cover operating results, customer cloud-capacity agreements, private placements of equity securities, senior notes, credit facilities, and related guarantees or collateral arrangements.
Proxy materials disclose annual meeting matters, stockholder voting items, board governance, executive compensation, and equity-award information. Capital-structure filings describe senior unsecured notes due 2031, subsidiary guarantees, private placement registration rights, and debt facilities used to finance GPU servers and related infrastructure for customer contracts.
CoreWeave, Inc. reported a Form 4 showing that investment entities advised by Magnetar Financial LLC executed open‑market sales of Class A Common Stock. On June 2, 2026, the Magnetar Funds sold a total of 112,111 shares in multiple transactions, at weighted average prices within ranges of $130.12–$131.00 and $131.32–$132.20, as disclosed in the footnotes. Following these trades, individual Magnetar‑advised funds continued to hold large indirect positions, including holdings such as 17,858,589 shares, 6,764,989 shares and other multi‑million‑share balances reported for specific Magnetar Funds. Magnetar Financial acts as investment adviser to the Magnetar Funds, while Magnetar Capital Partners LP, Supernova Management LLC and David J. Snyderman are upstream entities; each disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest.
CoreWeave, Inc. reported a Form 4 showing that investment funds advised by entities associated with Magnetar Financial LLC entered into a series of open-market sales of call options on June 1, 2026. These derivative sales cover an aggregate of 2,000,000 shares of CoreWeave Class A Common Stock, with a conversion or exercise price of $170.0000 per share and an exercise and expiration date of December 18, 2026.
The positions are held indirectly through multiple Magnetar-managed vehicles, including CW Opportunity 2 LP and other Magnetar Funds, which are advised or managed by Magnetar Financial and its affiliates. Magnetar Financial, Magnetar Capital Partners, Supernova Management and David J. Snyderman each disclaim beneficial ownership of the issuer’s common stock except to the extent of their pecuniary interests.
CoreWeave, Inc. Chief Operating Officer Sachin Jain reported an open-market sale of 3,798 shares of Class A Common Stock at $120.00 per share. After the sale, he directly holds 127,629 shares. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2025 and modified on November 20, 2025.
CRWV reported proposed sales of Common Stock under Rule 144 and scheduled 10b5-1 dispositions by affiliated trusts and entities. The excerpt lists multiple sale dates in April–May 2026 with per-trade share counts (examples: 300,000 shares on 04/20/2026, 493,600 shares on 04/01/2026) and accompanying gross proceeds figures in dollars. The sales are identified as 10b5-1 plan activity and include named holders such as WEST CLAY CAPITAL LLC, VENTURO FAMILY GST-EXEMPT TRUST, and BRIAN VENTURO.
CRWV — Notice of proposed sales of Common Stock. The filing lists multiple proposed or executed sales of Common shares by named holders, many described as 10b5-1 sales. Examples include large blocks by WEST CLAY CAPITAL LLC and recurring sales by the VENTURO FAMILY GST-EXEMPT TRUST, with transactions dated across March–May 2026. The filing records a Founders Shares line dated 12/27/2023.
CRWV submitted a Form 144 notice indicating proposed sale of 15,385 shares of Common Stock. The filing lists numerous recent 10b5-1 sales by affiliated entities and persons across multiple dates in March–May 2026, with individual lots ranging from 5,887 to 900,000 shares.
The cover lines show 15,385 and an associated amount of $1,834,968.95; the excerpt also records large prior 10b5-1 dispositions by West Clay Capital LLC and related trusts on Nasdaq-listed shares.
CoreWeave, Inc. director Jack D. Cogen reported indirect open‑market sales of Class A Common Stock through CW Holding 987 LLC. On May 29, 2026, entities associated with him sold a total of 271,153 shares in several transactions at weighted average prices of $106.2989, $107.1860, $108.2420 and $108.8225 per share. After these sales, CW Holding 987 LLC continued to hold 8,950,419 shares of Class A Common Stock indirectly associated with Cogen, and additional indirect holdings were reported across various family trusts and LLCs. Footnotes state that he disclaims beneficial ownership of certain securities except to the extent of any pecuniary interest.
CRWV files notices of proposed sales of Common stock by several holders, listing multiple transactions executed under 10b5-1 plans and other dispositions through spring 2026. The excerpt lists individual sale dates, share counts and gross proceeds for trades such as 05/26/2026 (200,000 shares, $21,348,100.00) and many similar entries.
The filing records prior conversions and restricted stock unit issuances dated 02/25/2019 and 03/31/2025, and shows cumulative per-trade dollar amounts alongside share counts.
The issuer's brokers and related holders reported multiple 10b5-1 sales of Common stock by named parties, including repeated sales attributed to Michael Intrator and Omnadora Capital LLC. The excerpt lists individual sale dates, share counts, and gross proceeds for transactions between 03/05/2026 and 05/26/2026.
The filings show repeated planned/disclosed dispositions under 10b5-1 arrangements and charitable transfers (Fidelity Charitable) over the period; timing and per-trade proceeds are presented line-by-line in the excerpt.
Issuer filed a Form 144 disclosing planned or proposed sales of Common Stock. The filing lists 3,798 Restricted Stock Units dated 05/08/2026 and multiple 10b5-1 sale transactions by Sachin Jain, including sales on 05/28/2026 for 898 shares and on 05/08/2026 for 14,750 shares. The filing itemizes dates and share counts for recent dispositions; timing of actual transfers is governed by the rules cited in the notice.